Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ The Ensign Group, Inc. (ENSG) Stock Forecast & Price Prediction United States | NASDAQ | Healthcare | Medical Care Facilities
$170.30
+6.01 (3.66%)Did ENSG Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Ensign Group is one of their latest high-conviction picks.
Based on our analysis of 3 Wall Street analysts, ENSG has a bullish consensus with a median price target of $222.00 (ranging from $210.00 to $230.00). The overall analyst rating is Strong Buy (8.8/10). Currently trading at $170.30, the median forecast implies a 30.4% upside. This outlook is supported by 4 Buy, 1 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for ENSG.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Feb 9, 2026 | RBC Capital | Ben Hendrix | Outperform | Maintains | $222.00 |
| Feb 6, 2026 | Truist Securities | David Macdonald | Hold | Maintains | $215.00 |
| Nov 14, 2025 | RBC Capital | Outperform | Maintains | $N/A | |
| Nov 10, 2025 | Truist Securities | Hold | Maintains | $N/A | |
| Nov 5, 2025 | UBS | Buy | Maintains | $N/A | |
| Nov 5, 2025 | Stephens & Co. | Overweight | Maintains | $N/A | |
| Sep 2, 2025 | UBS | Buy | Maintains | $N/A | |
| Aug 14, 2025 | UBS | Buy | Maintains | $N/A | |
| Jul 28, 2025 | Truist Securities | Hold | Maintains | $N/A | |
| Jul 28, 2025 | Stephens & Co. | Overweight | Maintains | $N/A | |
| May 2, 2025 | Macquarie | Outperform | Maintains | $N/A | |
| Feb 7, 2025 | Stephens & Co. | Overweight | Maintains | $N/A | |
| Feb 6, 2025 | Stephens & Co. | Overweight | Reiterates | $N/A | |
| Feb 4, 2025 | Macquarie | Outperform | Maintains | $N/A | |
| Jan 6, 2025 | Truist Securities | Hold | Maintains | $N/A | |
| Nov 21, 2024 | UBS | Buy | Initiates | $N/A | |
| Oct 28, 2024 | RBC Capital | Outperform | Maintains | $N/A | |
| Oct 28, 2024 | Stephens & Co. | Overweight | Maintains | $N/A | |
| Oct 28, 2024 | Truist Securities | Hold | Maintains | $N/A | |
| Oct 25, 2024 | Oppenheimer | Outperform | Maintains | $N/A |
The following stocks are similar to Ensign Group based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
The Ensign Group, Inc. has a market capitalization of $9.95B with a P/E ratio of 26.8x. The company generates $5.27B in trailing twelve-month revenue with a 6.9% profit margin.
Revenue growth is +18.4% quarter-over-quarter, while maintaining an operating margin of +9.0% and return on equity of +16.9%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Provides post-acute healthcare services.
The company operates through independent subsidiaries offering skilled nursing, senior living, and rehabilitative therapies. It generates revenue primarily from its Skilled Services segment, which provides nursing care and specialty services, and from leasing post-acute care properties through its Standard Bearer segment.
Founded in 1999 and headquartered in San Juan Capistrano, California, the company emphasizes resident-centered care and operates across multiple states, providing a range of ancillary services to enhance patient care.
Healthcare
Medical Care Facilities
46,000
Mr. Barry R. Port
United States
2007
The Ensign Group, Inc. acquired the 62-bed Woodland Health and Rehabilitation facility in Mount Pleasant, Iowa, effective June 1, 2026, through its subsidiary Standard Bearer Healthcare REIT.
The Ensign Group's acquisition expands its real estate holdings and operational capacity in skilled nursing, potentially enhancing revenue and market presence, which can positively impact stock performance.
Ensign Group has expanded its portfolio to 396 healthcare operations and 181 owned real estate properties through recent acquisitions in California and Iowa.
Ensign Group's expansion signals growth potential and increased market share, likely enhancing revenue and profitability, which can positively influence stock performance.
Ensign Group, Inc. acquired the real estate for a 46-unit memory care facility in Pleasant Hill, California, through its subsidiary, under a long-term triple net lease.
The Ensign Group's acquisition of a memory care facility expands its portfolio, potentially increasing revenue and stability through long-term leases, which could enhance investor confidence and stock performance.
Purcell & Lefkowitz LLP is investigating The Ensign Group, Inc. (NASDAQ: ENSG) for potential breaches of fiduciary duties by its directors related to recent corporate actions.
The investigation into The Ensign Group's directors could signal potential governance issues, affecting stock performance and shareholder confidence.
Ensign Group exceeded Q1 EPS estimates due to occupancy gains and acquisitions, but faced higher costs and a slight revenue miss.
Ensign Group's strong EPS performance indicates robust growth potential, but rising costs and revenue miss may signal caution, impacting future earnings and investor sentiment.
The Ensign Group, Inc. (ENSG) held its Q1 2026 earnings call, providing insights into its financial performance and operational strategies. Further details are available in the transcript.
The Ensign Group's Q1 2026 earnings call provides insights into financial performance, growth strategies, and market trends, crucial for assessing investment potential and future profitability.
Based on our analysis of 3 Wall Street analysts, The Ensign Group, Inc. (ENSG) has a median price target of $222.00. The highest price target is $230.00 and the lowest is $210.00.
According to current analyst ratings, ENSG has 4 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $170.30. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict ENSG stock could reach $222.00 in the next 12 months. This represents a 30.4% increase from the current price of $170.30. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company operates through independent subsidiaries offering skilled nursing, senior living, and rehabilitative therapies. It generates revenue primarily from its Skilled Services segment, which provides nursing care and specialty services, and from leasing post-acute care properties through its Standard Bearer segment.
The highest price target for ENSG is $230.00 from at , which represents a 35.1% increase from the current price of $170.30.
The lowest price target for ENSG is $210.00 from at , which represents a 23.3% increase from the current price of $170.30.
The overall analyst consensus for ENSG is bullish. Out of 3 Wall Street analysts, 4 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $222.00.
Stock price projections, including those for The Ensign Group, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.